Ctnnb1 Mouse shRNA Lentiviral Particle and 1 more item

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, awarded a purchase order (PO) contract to OriGene Technologies Inc., a vendor based in Rockville, Maryland, for specialized biological research materials. The contract, identified as 4800153096, involves the procurement of two distinct lentiviral particle products: two units of Ctnnb1 Mouse shRNA Lentiviral Particles priced at $1,731.00 each, and one unit of Control Lenti particles with Scrambled shRNA priced at $365.00.

The total contract value is $3,827.00, with a brief performance period from October 23, 2025, to October 29, 2025. The purchase order specifies delivery to UNMC Shipping and Receiving, with payment terms set at Net 30 and shipment conditions of F.O.B. destination and freight prepaid. The specific delivery location is noted as DRC 1 6034, suggesting a precise internal campus delivery point. The contract appears to support scientific research requiring specialized genetic modification tools, specifically RNA interference (RNAi) lentiviral particles for mouse-based studies.